Optometrist Memphis VAMC Memphis, Tennessee, United States
Disclosure(s): No relevant disclosure to display
Disclosure(s):
Andrew Rixon, OD: No relevant disclosure to display
OCT angiography has emerged as a technology capable of capturing, in vivo, the microvasculature of the neural and connective tissues damaged by glaucoma. OCT-A has the potential to identify vascular dysregulation in certain patients; increasing the possibility of more customized care. This lecture will explore the latest research on OCT-A and Glaucoma, present cases on how it currently enhances glaucoma care in practice and discuss whether it will become a standard in glaucoma management.
Learning Objectives:
Upon conclusion of this activity, attendees will be able to:
Review how OCT-A captures the circumpapillary and macular vasculature
Discuss the diagnostic and management capabilites of OCT-A across the glaucoma spectrum
Discuss the potential for OCT-A to extend the range of disease monitoring that cannot be accomplished with other technologies
Highlight current limitations and future uses of OCT A in glaucoma